Nitric Oxide Services, LLC (NOS), is a consulting and research firm specializing in the investigation, evaluation, and application of nitric oxide and related substances in various health and medical contexts. We have a strong reputation in the field, owing to our experienced team of researchers, clinicians, and consultants who have a comprehensive understanding of the complex biochemistry of nitric oxide and its potential benefits in the human body.
Our secured-access laboratory is housed on the campus of Walsh University in the St. John Paul II Center for Science Innovation which has access to state of the art analytical equipment, tissue culture, and chemical reactors.
Nitric Oxide Services has access to proprietary nitric oxide-donor compounds, synthesis facilities and analytical methods and instrumentation which provides a comprehensive platform to meet the challenge of any NO-based research project from inception to completion. To learn more about our capabilities, click below:
We are nitric oxide capable™
IN THE NEWS
(click on the text to access article or presentation)
SAVE THE DATE!
Dr. Bauer, an expert in nitric oxide, (President of Nitric Oxide Services, LLC) will be presenting on behalf of Plasma Futures’ nitric oxide generating platform “Nonthermal Plasma Directed Electron Beam (NT-PDEB™) as a Treatment Modality for Wound Healing in Combat Casualty Care and Military Operational Medicine; MHSRS-23-10578” at the 2023 Military Health Science Research Symposium (MHSRS) in the Breakout Session “Tissue Wound Management for Prolonged Care Environments” on Tuesday August 15th at 8:30 am.
Dr. Bauer discusses Cancer Drug Discovery and Development to students and faculty of the Center for Molecular Biology and Biotechnology (CMBB) Fall 2022 Virtual Lecture Series on January 24, 2022 at Florida Atlantic University.
Sysel AM, Dunphy MJ, Bauer JA. Antimicrobial properties of diethylamine NONOate, a nitric oxide donor, against Escherichia coli: a pilot study. J Antibiotics . 2021 Apr;74(4):260-265. doi: 10.1038/s41429-020-00397-9. Epub 2020 Dec 28. PMID: 33361779; PMCID: PMC7767638.
Bauer JA, Lupica JA, Didonato JA, Lindner DJ. Nitric Oxide Inhibits NF-κB-mediated Survival Signaling: Possible Role in Overcoming TRAIL Resistance. Anticancer Res. 2020 Dec;40(12):6751-6763. doi: 10.21873/anticanres.14698. Epub 2020 Dec 7. PMID: 33288568.
Sysel AM, Dunphy MJ, Lindner DJ, DiDonato JA, Lupica JA, Bauer JA. Comment on the importance of using nitric oxide gas in the synthesis of nitrosylcobalamin and ICH-validated methods to assess purity and stability. J Biol Chem. 2020 Oct 23;295(43):14789. doi: 10.1074/jbc.L120.016007. PMID: 33097647; PMCID: PMC7586211.
Dr. Bauer receives Long Service Editorial Board Member Award from PLoS ONE. February 28, 2023.
dedicated to the research and development of Nitric oxide